Imre Noth MD
Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Professor of Medicine
Join to View Full Profile
1221 Hospital DrFl 2Charlottesville, VA 22908
Phone+1 434-924-5219
Fax+1 434-244-7509
Dr. Noth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 1999
University of California Davis HealthResidency, Internal Medicine, 1992 - 1995
University of Arizona College of MedicineClass of 1992
Certifications & Licensure
AZ State Medical License 1995 - Present
CA State Medical License 1993 - Present
VA State Medical License 2018 - 2028
IL State Medical License 1996 - 2020
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
- A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations Start of enrollment: 2005 Jan 01
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Start of enrollment: 2007 Aug 01
Publications & Presentations
PubMed
- 1 citationsPolygenic risk and rare variants in endotypes of idiopathic pulmonary fibrosis: a genetic analysis of population-based and case-control cohorts.Anna Duckworth, Leigh Jackson, Harry Green, Atlas Khan, Chen Wang
The Lancet. Respiratory Medicine. 2026-04-01 - MMP12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates with Antigen Response Pathways.Sam B Konkol, Yong Huang, Shwu-Fan Ma, Stephen Humphries, David Lynch
Chest. 2026-03-07 - Sex-related transcriptomic differences in idiopathic pulmonary fibrosis.Aravind A Menon, Matthew Moll, Janelle V Pugashetti, Angela L Linderholm, Gabrielle Y Liu
American Journal of Respiratory and Critical Care Medicine. 2026-02-21
Other
- Management of the patient with severe COPD and cardiovascular diseaseNoth I, Schmidt GA
http://www.uptodate.com/contents/management-of-the-patient-with-severe-copd-and-cardiovascular-disea
UpToDate, Wolters Kluwer Health - 2013-02-12
Press Mentions
iTHRIV Backs Promising Researchers to Improve Patient CareJune 10th, 2024- Antibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyJune 4th, 2021
Ofev Doubles the Chance of Improving or Stabilizing IPFMay 26th, 2017
Grant Support
- The role of quantitative CT and radiomic biomarkers for precision medicine in pulmonary fibrosisUNIVERSITY OF VIRGINIA2024–2029
- 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUNIV OF MASSACHUSETTS MED SCH WORCESTER2024–2026
- Genome-Wide Association And EXON Sequencing Study In IPFNational Heart, Lung, And Blood Institute2009–2010
- Combination Therapy In IPFNational Heart, Lung, And Blood Institute2005–2009
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
